To further investigate mechanistic insights into the role of BRM in RCC, we involved all genes that were significantly correlated with BRM expression in TCGA tumor tissues (PFDA<0.01 and Person>0.3). This evidence concerns the gene SMARCA2 and renal cell carcinoma.